Monitor cleaning after validation
Monitor validated cleaning procedures at appropriate intervals during production.
CV-REQ-000018
Q7A: Good Manufacturing Practice for APIs§ 12.7 — ongoing monitoring
TOPIC EXPLORER
Revalidation
Evaluating the effect of change on an established cleaning process.
3 connected references
Review the validated state
Periodically evaluate whether systems remain in a valid state.
CV-REQ-000019
Q7A: Good Manufacturing Practice for APIs§ 12.6
Manage the cleaning lifecycle
Connect cleaning development, qualification and ongoing monitoring.
CV-REQ-000024
Cleaning validation guide (GUI-0028)§ 7
Practical guidance
The State of Cleaning Validation 2026: Five Developments Reshaping the Field
Two years of regulatory revision, enforcement, new standards, tighter analytics and a first serious statistics stack have moved cleaning validation out of the appendix and into the centre of GMP. Five developments define where the field stands in September 2026 — and each one changes something a programme owner has to decide.
From Three Runs to Lifecycle Control: What Continued Cleaning Verification Really Means
The three-run cleaning validation was never a requirement — it was the convention that grew where guidance was silent. PI 006-4, the ASTM cleaning standards and three recent FDA warning letters all point at the same thing: what has to be maintained is a validated state, and continued cleaning verification is how you know it still holds.
PIC/S Publishes PI 006-4: A New Qualification and Validation Recommendation Takes Effect in October
PIC/S has published PI 006-4, the revised Recommendations on Qualification and Validation, superseding the 2007 PI 006-3 and entering into force on 1 October 2026. Cleaning validation now occupies a full chapter, with HBEL-driven scope, explicit limits on visual inspection and a clear position against continued test-until-clean practice.
What FDA Has Been Citing in Cleaning Validation: The Recurring Themes of 2025–2026
Twelve FDA warning letters issued between 3 December 2024 and 24 July 2026 cite cleaning and cross-contamination control. Read together rather than case by case, they stop looking like twelve incidents and start looking like one audit checklist: worst-case selection, hold times, recovery, MACO justification, visual-only strategies, sampling locations, change control and lifecycle management — in that order of frequency.
Annex 15 Corrigendum: Small Text, Big Consequences for Cleaning Teams
EMA and PIC/S reissued the January 2026 Annex 15 concept paper in July 2026 with a new reference number and a substantially longer timetable. Nothing about cleaning validation itself changed — but the dates most teams are planning against did.
Worst Case or Product-Specific? New Research Reopens the Cleaning Validation Strategy Debate
A comparative review in the PDA Journal weighs worst-case matrices against product-specific validation and proposes a hybrid model anchored on visible residue limits.
Released as Clean, Yet Residue Remained: A Simple Finding With a Bigger System Lesson
An FDA investigator found white residue inside Tank #68 at Chemco Corporation — equipment the quality unit had already verified as clean. The finding itself is mundane. What it exposes about release decisions, shared equipment and the absence of cleaning validation is not.
EU and PIC/S Start the Next Revision of Annex 15 — What Validation Teams Should Watch
A joint EMA–PIC/S concept paper proposes extending Annex 15 to active substance manufacturers and aligning it with ICH Q9(R1). The current Annex 15 stays in force, and the earliest a revised text could be published is 2028.
A Cleaning Verification Programme Is Only Useful If It Can Detect the Risk
FDA Warning Letter 320-26-40 to Cohance Lifesciences did not turn on a single residue number. It turned on whether the firm's verification programme could have found the carryover at all — and whether its worst-case basis was ever revisited.
AI Enters Continued Cleaning Process Verification — but the Statistics Come First
A January 2026 AAPS PharmSciTech paper proposes normalising every residue result to a percentage of its own specification limit, so that cleaning data from different products can finally be pooled, analysed non-parametrically and monitored as a Stage 3 capability index. The statistical argument is the substance; the AI framing is thinner than the title suggests.
When the Cleaning Validation No Longer Matches the Factory
FDA's December 2025 letter to Medinatura New Mexico records a firm acknowledging that its cleaning validation was not reflective of current operations after years of buying new equipment and adding new products. What the gap looks like from the inside — and what it asks of change control.
A Cleaning Validation Can Age: What Happens When Products Change but the Study Does Not
The FDA's August 2025 warning letter to ABBE Laboratories describes a 2009 cleaning validation still standing while a harder-to-clean product was introduced onto the same shared kettle — and no change-control step that caught it.
INTERPHEX 2025: Process Monitoring Reaches the Cleaning Suite
INTERPHEX 2025 in New York put cleaning validation on the process-monitoring agenda: a dedicated panel on analytics, contamination control and sustainability, plus cleanroom and environmental-monitoring sessions. Industry-press report from Javits Center, 1-3 April 2025.
FDA Again Links Shared Equipment to the Need for a Lifecycle Cleaning Programme
A December 2024 warning letter to Brands International Corporation cites the firm under 21 CFR 211.67(b) for failing to perform cleaning validation studies on non-dedicated equipment — and asks for a cleaning programme built around worst-case products, worst-case swab sites and maximum hold times before cleaning.
When Shared Equipment Has Never Been Cleaning-Validated: Lessons From an FDA Warning Letter
An FDA Warning Letter to Indian API manufacturer Micro Orgo Chem describes non-dedicated equipment that had never been cleaned under a validated procedure, cleaning SOPs that were not followed, and no evidence that the rinse and swab samples required by the firm's own procedure were ever collected or tested.
ASTM Puts Process Capability on the Cleaning Validation Agenda
ASTM work item WK92658 wants to standardise how cleaning processes are judged capable — one-sided limits, small data sets, non-normal residues and continued verification included. It is the statistical gap E3106 left open.